|Previous Section||Index||Home Page|
4 Dec 2002 : Column 902Wcontinued
Tim Loughton: To ask the Secretary of State for Health which developing countries have offered warm support, as stated by a Department of Health spokesman on 26 November, for the Government's approach to ethical international recruitment. 
Ms Blears: In 1999, the Government made a commitment to develop and expand the Liverpool Blood Centre. A new building to house the Liverpool Blood Centre is currently under construction. The centre at Estuary Commerce Park in Speke, Garston will replace the existing premises adjacent to the Royal Liverpool University Hospital. Completion of the construction phase is expected by mid-October 2003, and occupation is anticipated in summer 2004.
Almost all services currently carried out at the existing premises will transfer to the new centre. Those services that have to be carried out in a hospital environment will remain at the Royal Liverpool Hospital. The new Liverpool Blood Centre will also house, for the first time, the largest National Blood
4 Dec 2002 : Column 903W
Dr. Evan Harris: To ask the Secretary of State for Health what progress has been made towards implementing NICE guidance on the use of atypical anti-psychotic medicines for schizophrenia; and if he will make a statement. 
Mr. Hutton: Epsom and St. Helier is working towards the elimination of mixed sex wards in order to provide patients with appropriate levels of privacy and dignity while in hospital. The trust is currently undertaking works to refurbish Nightingale wards for older people, which will provide privacy and peace within a single-sex environment. The trust's programme of works extends until April 2004.
Mr. Hunter: To ask the Secretary of State for Health whether it is his policy that the Medicines Control Agency should limit the maximum number of authorisations for imports of MMR SepVax (Mumps) doses; what the equivalent is in daily individual doses of the number of authorisations of MMR SepVax (Mumps) vaccines which the MCA is approving; and if he will make a statement on (a) the availability of MMR SepVax (Mumps) in relation to demand for vaccination and (b) the delays which customers are experiencing in obtaining supplies of MMR SepVax (Mumps) vaccines. 
Ms Blears: Single mumps vaccines being prescribed and administered, as part of single measles, mumps and rubella vaccination programmes such as MMR SepVax, are unlicensed imported medicines. Medicines legislation allows a doctor or dentist to prescribe an unlicensed medicine to meet the special clinical needs of his individual patients, on his direct personal responsibility. Importers of all unlicensed medicines, who are licensed by the Medicines Control Agency (MCA), must notify the agency on each occasion they intend importing an unlicensed medicine and there is a legal restriction on the maximum quantity they may import per notification. The MCA can object to importation if it has safety concerns or if an equivalent licensed medicine is available. This applies to all imported unlicensed medicines; there is no policy of specifically restricting unlicensed single measles and mumps vaccines.
4 Dec 2002 : Column 904W
Safety concerns about vaccines containing the Urabe and Leningrad-Zagreb strains of mumps virus;
Efficacy concerns about vaccines containing the Rubini strain of mumps virus;
The recent need to obtain further information on the safety and efficacy of another unlicensed single vaccine claiming to contain a Jeryl Lynn strain of mumps virus.
Mr. Lammy: It is not feasible to monitor centrally every clinical decision for consistency with National Institute of Clinical Excellence (NICE) guidance. Clinicians have to make independent clinical judgments, taking due account of NICE'S advice and the strength of evidence which lies behind it. They may depart from the advice if in their view the circumstances of the individual patient justify doing so, but they will be held accountable (through clinical governance arrangements) for their clinical decisions.
Mrs. Gillan: To ask the Secretary of State for Health what the ratio was of NHS general dental practitioners to population; and how many NHS general dental practitioners there were in (a) Chesham and Amersham and (b) Buckinghamshire in each year since 1 January 1996. 
Mr. Lammy [holding answer 3 December 2002]: The number of general dental service (GDS) practitioners in Buckinghamshire health authority (HA) area at 30 September and the ratio of GDS practitioners per 100,000 population is shown in the table for the years 1996 to 2001.
4 Dec 2002 : Column 905W
|Number of dentists|
|Year||At 30 September||Per 100,000 population|
(40) Dentists are principals on a HA list, assistants and vocational dental practitioners.
(41) ONS 1996 to 2000 mid year population estimates based on the 1991 census. ONS 2001 mid year population estimate is based on 2001 census; using a population estimate based on 1991 census would change the 2001 dentists per 100,000 population figure to 42.0.
Sir Nicholas Winterton: To ask the Secretary of State for Health when he will publish the aggregated results of the Estate Return Information Collection annual condition survey for 200001 and 200102; for what reason publication has been delayed; and if he will publish results of future ERIC surveys within six months of the survey's completion. 
Mr. Lammy: Since 2000, estate return information collection (ERIC) data can be entered on line, which provides trusts with 'real time' calculations of their performance indicator information together with comparative benchmarking data from trusts of the same type.
A detailed analysis of performance data extracted from the ERIC is currently being undertaken with the view to publishing a hard copy report next year that will cover the three year period, 19992000 to 200102.
Dr. Murrison: To ask the Secretary of State for Health what assessment he has made of the value of land with development potential held by the NHS, broken down (a) by NHS trust and (b) by strategic health authority region. 
National health service trusts are responsible for the management and disposal of their estate. In preparing their estate strategies, NHS trusts will have regard to the current and future operational needs and will consider potential value for alternative uses.
4 Dec 2002 : Column 906W
|Next Section||Index||Home Page|